Monopar Therapeutics (MNPR) Operating Expenses (2017 - 2025)

Quarterly results put Operating Expenses at $4.1 million for Q3 2025, up 159.89% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 75.65% YoY), and the annual figure for FY2024 was $4.0 million, changed.

Monopar Therapeutics has reported Operating Expenses over the past 9 years, most recently at $4.1 million for Q3 2025.

  • Operating Expenses reached $4.1 million in Q3 2025 per MNPR's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $4.1 million in Q3 2025 and bottomed at $918634.0 in Q4 2024.
  • Median Operating Expenses over the past 5 years was $2.4 million (2022), compared with a mean of $2.4 million.
  • The largest annual shift saw Operating Expenses tumbled 31.75% in 2024 before it skyrocketed 159.89% in 2025.
  • Over 5 years, Operating Expenses stood at $2.7 million in 2021, then increased by 8.5% to $2.9 million in 2022, then dropped by 28.98% to $2.1 million in 2023, then plummeted by 55.54% to $918634.0 in 2024, then soared by 345.56% to $4.1 million in 2025.
  • Business Quant data shows Operating Expenses for MNPR at $4.1 million in Q3 2025, $3.2 million in Q2 2025, and $3.2 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 2.97 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 4.33 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.85 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 2.96 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.82 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 898.54 Mn
10 Monopar Therapeutics 466.82 Mn 466.82 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 4.09 Mn
Jun 30, 2025 3.23 Mn
Mar 31, 2025 3.22 Mn
Dec 31, 2024 918,634.00
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.79 Mn
Mar 31, 2024 1.72 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 2.33 Mn
Mar 31, 2023 2.53 Mn
Dec 31, 2022 2.91 Mn
Sep 30, 2022 2.41 Mn
Jun 30, 2022 2.76 Mn
Mar 31, 2022 2.46 Mn
Dec 31, 2021 2.68 Mn
Sep 30, 2021 2.46 Mn
Jun 30, 2021 2.09 Mn
Mar 31, 2021 1.89 Mn
Dec 31, 2020 2.26 Mn
Sep 30, 2020 1.65 Mn
Jun 30, 2020 1.46 Mn
Mar 31, 2020 1.14 Mn
Dec 31, 2019 1.22 Mn
Sep 30, 2019 759,448.00
Jun 30, 2019 932,109.00
Mar 31, 2019 1.41 Mn
Dec 31, 2018 926,358.00
Sep 30, 2018 667,532.00
Jun 30, 2018 667,532.00
Mar 31, 2018 897,260.00
Dec 31, 2017 736,800.00
Sep 30, 2017 14.90 Mn
Jun 30, 2017 594,957.00
Mar 31, 2017 373,839.00